KLF4 is a key determinant in the development and progression of cerebral cavernous malformations
Abstract Cerebral cavernous malformations (CCMs) are vascular malformations located within the central nervous system often resulting in cerebral hemorrhage. Pharmacological treatment is needed, since current therapy is limited to neurosurgery. Familial CCM is caused by loss‐of‐function mutations in...
Saved in:
| Main Authors: | Roberto Cuttano, Noemi Rudini, Luca Bravi, Monica Corada, Costanza Giampietro, Eleanna Papa, Marco Francesco Morini, Luigi Maddaluno, Nicolas Baeyens, Ralf H Adams, Mukesh K Jain, Gary K Owens, Martin Schwartz, Maria Grazia Lampugnani, Elisabetta Dejana |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2015-11-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201505433 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defective autophagy is a key feature of cerebral cavernous malformations
by: Saverio Marchi, et al.
Published: (2015-09-01) -
Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations
by: Cécile Otten, et al.
Published: (2018-09-01) -
Endothelial–Mesenchymal Transition and Possible Role of Cytokines in Streptozotocin-Induced Diabetic Heart
by: Hsu Lin Kang, et al.
Published: (2025-05-01) -
Late‐Stage Skeletal Muscle Transcriptome in Duchenne Muscular Dystrophy Shows a BMP4‐Induced Molecular Signature
by: Hanna Sothers, et al.
Published: (2025-08-01) -
New insight into the significance of KLF4 PARylation in genome stability, carcinogenesis, and therapy
by: Zhuan Zhou, et al.
Published: (2020-11-01)